Skip to content

Efficacy of a Multimodal Physical Activity Intervention in Patients With Chronic Nonspecific Low Back Pain

Efficacy of a Multimodal Physical Activity Intervention With Supervised Exercises, Health Coaching and an Activity Monitor on Physical Activity Levels of Patients With Chronic Nonspecific Low Back Pain: PAyBACK Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03200509
Acronym
PAyBACK
Enrollment
160
Registered
2017-06-27
Start date
2017-08-31
Completion date
2019-08-15
Last updated
2019-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Keywords

nonspecific low back pain, chronic pain

Brief summary

Physical activity plays an important role in the management of chronic low back pain (LBP). Engaging in an active lifestyle is associated with a better prognosis. Nevertheless, there is evidence to suggest that patients with chronic LBP are less likely to meet recommended physical activity levels. Furthermore, while exercise therapy has been endorsed by recent clinical practice guidelines, evidence from systematic reviews suggests that its effect on pain and disability are at best moderate and not sustained over time. A limitation of current exercises programs for chronic LBP is that these programs are not designed to change patient's behaviour toward an active lifestyle. Therefore, the objective of this study is to investigate the short and long-term efficacy of a multimodal intervention consisting of supervised exercises, health coaching and use of an activity monitor (i.e. Fitbit Flex) compared to supervised exercises plus sham coaching and a sham activity monitor on physical activity levels, pain intensity and disability in patients with chronic nonspecific LBP.

Interventions

OTHERPhysical Activity Intervention

Participants will receive a group exercise program, health coaching sessions and an activity monitor.

OTHERControl group

Participants will receive a group exercise program, sham health coaching sessions and a sham activity monitor.

Sponsors

University of Sydney
CollaboratorOTHER
Universidade Estadual Paulista Júlio de Mesquita Filho
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Chronic nonspecific LBP, defined as pain and discomfort localised below the costal margin and above the inferior gluteal folds, with or without leg pain and of at least 3 months' duration

Exclusion criteria

* Serious spine pathology (e.g. tumors, fractures, and inflammatory diseases) * Nerve root compromise (i.e. at least 2 of the following signs: weakness, reflex change, or sensation loss associated with the same spinal nerve) * Spinal surgery * Pregnancy * Illiteracy * Insufficient understanding of the Portuguese language * Cardiorespiratory Diseases fibromyalgia or any other musculoskeletal condition that may affect activity and movement will be excluded

Design outcomes

Primary

MeasureTime frameDescription
Physical activity levels - Counts per minutePost-intervention (i.e. 3 months after randomisation)Counts per minute will be measured with the Actigraph GT3X (ActiGraph, LLC, Pensacola, FL, USA).
Pain intensityPost-intervention (i.e. 3 months after randomisation)Numerical Rating Scale for Pain assessment (NRS) (0-10)
DisabilityPost-intervention (i.e. 3 months after randomisation)Roland Morris Disability Questionnaire (RMDQ) (0-24)

Secondary

MeasureTime frameDescription
Physical activity levels - light physical activityPost-intervention (i.e. 3 months after randomisation) and at 6 and 12-month follow-upTime spent in light physical activity will be measured with the Actigraph GT3X (ActiGraph, LLC, Pensacola, FL, USA).
Physical activity levels - moderate-to-vigorous physical activityPost-intervention (i.e. 3 months after randomisation) and at 6 and 12-month follow-upTime spent in moderate-to-vigorous physical activity will be measured with the Actigraph GT3X (ActiGraph, LLC, Pensacola, FL, USA).
Physical activity levels - stepsPost-intervention (i.e. 3 months after randomisation) and at 6 and 12-month follow-upNumber of steps will be measured with the Actigraph GT3X (ActiGraph, LLC, Pensacola, FL, USA).
Sedentary behaviorPost-intervention (i.e. 3 months after randomisation) and at 6 and 12-month follow-upTime spent in sedentary behavior will be measured with the Actigraph GT3X (ActiGraph, LLC, Pensacola, FL, USA).
Self-reported physical activity levelPost-intervention (i.e. 3 months after randomisation) and at 6 and 12-month follow-upBaecke Habitual Physical Activity Questionnaire
Self-reported sedentary behaviorPost-intervention (i.e. 3 months after randomisation) and at 6 and 12-month follow-upQuestions about the time spent in sedentary behavior
Physical activity levels - Counts per minute6 and 12-month assessment after randomisationCounts per minute will be measured with the Actigraph GT3X (ActiGraph, LLC, Pensacola, FL, USA).
General quality of lifePost-intervention (i.e. 3 months after randomisation) and at 6 and 12-month follow-upEuroQol visual analogue scale (EQ-VAS) (0-100)
Pain self-efficacyPost-intervention (i.e. 3 months after randomisation) and at 6 and 12-month follow-upPain Self-Efficacy Questionnaire (PSEQ) (0-60)
Weight-related outcomes - Body mass indexPost-intervention (i.e. 3 months after randomisation) and at 6 and 12-month follow-upBody mass index
Weight-related outcomes - Waist-to-hip circumferencePost-intervention (i.e. 3 months after randomisation) and at 6 and 12-month follow-upWaist-to-hip circumference
Global Perceived Effect Scale (GPES)Post-intervention (i.e. 3 months after randomisation)Perception of recovery
DepressionPost-intervention (i.e. 3 months after randomisation) and at 6 and 12-month follow-upThe Center for Epidemiological Studies - Depression (CES-D) scale (0-60)
Pain intensity6 and 12-month assessment after randomisationNumerical Rating Scale for Pain assessment (NRS) (0-10)
Disability6 and 12-month assessment after randomisationRoland Morris Disability Questionnaire (RMDQ) (0-24)

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026